These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 20708056
1. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats. Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec 01; 34(8):1455-64. PubMed ID: 20708056 [Abstract] [Full Text] [Related]
2. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors. Zwart R, Carbone AL, Moroni M, Bermudez I, Mogg AJ, Folly EA, Broad LM, Williams AC, Zhang D, Ding C, Heinz BA, Sher E. Mol Pharmacol; 2008 Jun 01; 73(6):1838-43. PubMed ID: 18367540 [Abstract] [Full Text] [Related]
3. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Turner JR, Wilkinson DS, Poole RL, Gould TJ, Carlson GC, Blendy JA. Neuropsychopharmacology; 2013 Sep 01; 38(10):2035-47. PubMed ID: 23624742 [Abstract] [Full Text] [Related]
9. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice. de Moura FB, McMahon LR. Psychopharmacology (Berl); 2017 Mar 01; 234(5):781-792. PubMed ID: 28028600 [Abstract] [Full Text] [Related]
10. Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. Gould RW, Czoty PW, Nader SH, Nader MA. J Pharmacol Exp Ther; 2011 Nov 01; 339(2):678-86. PubMed ID: 21856860 [Abstract] [Full Text] [Related]
11. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo. Ortiz NC, O'Neill HC, Marks MJ, Grady SR. Nicotine Tob Res; 2012 Jun 01; 14(6):711-9. PubMed ID: 22241831 [Abstract] [Full Text] [Related]
15. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats. Freitas K, Carroll FI, Negus SS. Exp Clin Psychopharmacol; 2016 Feb 01; 24(1):65-75. PubMed ID: 26461167 [Abstract] [Full Text] [Related]
16. Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats. Zaniewska M, McCreary AC, Stefański R, Przegaliński E, Filip M. Synapse; 2008 Dec 01; 62(12):935-9. PubMed ID: 18798299 [Abstract] [Full Text] [Related]
17. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Zaniewska M, McCreary AC, Przegaliński E, Filip M. Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696 [Abstract] [Full Text] [Related]
18. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats. Spiller K, Xi ZX, Li X, Ashby CR, Callahan PM, Tehim A, Gardner EL. Neuropharmacology; 2009 Jul 01; 57(1):60-6. PubMed ID: 19393252 [Abstract] [Full Text] [Related]
19. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M. Psychopharmacology (Berl); 2007 Feb 01; 190(2):157-70. PubMed ID: 17115136 [Abstract] [Full Text] [Related]
20. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. Trends Pharmacol Sci; 2007 Jul 01; 28(7):316-25. PubMed ID: 17573127 [Abstract] [Full Text] [Related] Page: [Next] [New Search]